During the three-month Y Combinator program, biotech companies focus on refining their go-to-market strategy and understanding market requirements, which helps them secure necessary funding and capital.

During the three-month Y Combinator program, the entire team focuses solely on growing the company and its numbers, which is extremely beneficial.

Remote operations have allowed Y Combinator to widen its net, enabling startups from around the world to participate without relocating to Silicon Valley.

After exiting Y Combinator, we achieved $200,000 in revenue within six weeks, and by the end of the year, we reached about $1 million, showcasing our rapid growth trajectory.

Many founders applying to Y Combinator are unaware of the full extent of the program's offerings, including ongoing support after the initial three-month period.

The intensity of the Y Combinator experience was high, with weekly dinners and a fixed three-month timeline leading up to demo day.

I advise companies going to Y Combinator to leverage the connections and mentorship available there to craft growth strategies for their solid products.

Investors in Y Combinator companies are top-tier VCs, frequently investing in these startups and often making multiple investments.

The last three batches of Y Combinator have consistently grown their revenue by 10% week on week, a feat not seen before in previous cycles.